BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2114722)

  • 1. Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report.
    Metzger U; Laffer U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Mueller W; Schweizer W
    Acta Chir Scand; 1990; 156(6-7):467-74. PubMed ID: 2114722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Final evaluation of the randomized multicenter study SAKK 40/81: adjuvant portal chemotherapy of curatively resected colorectal cancer].
    Laffer U; Metzger U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Müller W; Schweizer W
    Helv Chir Acta; 1992 Mar; 58(5):755-8. PubMed ID: 1592650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81)].
    Metzger U; Laffer U; Egeli R; Barras J; Martinoli S; Müller W; Arma S; Bär HU; Schweizer W; Aeberhard P
    Helv Chir Acta; 1989 Dec; 56(4):455-60. PubMed ID: 2517282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of portal perfusion in colorectal cancer. Swiss Study Group for Clinical Cancer Research].
    Metzger U; Laffer U; Egeli R; Arma S; Aeberhard P; Barras JP; Martinoli S; Müller W; Castiglione M; Schroeder R
    Chirurg; 1994 Jun; 65(6):509-13. PubMed ID: 8088206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Following curative resection of colorectal cancer, portal chemotherapy especially benefits non-transfused patients].
    Harder F; Laffer U; Berres M; Jäggi P; Metzger U
    Chirurg; 1990 Apr; 61(4):280-5. PubMed ID: 2112083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant portal liver infusion with 5-fluorouracil and mitomycin in colorectal cancer. SAKK.
    Weber W; Laffer U; Metzger U
    Anticancer Res; 1993; 13(5C):1839-40. PubMed ID: 8267390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.
    J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
    Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
    J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intra-portal chemoprevention and therapy of liver metastases].
    Laffer U
    Z Gastroenterol Verh; 1989 Jul; 24():189-91. PubMed ID: 2474948
    [No Abstract]   [Full Text] [Related]  

  • 14. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
    Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
    J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK).
    Eur J Surg; 1997 Sep; 163(9):693-701. PubMed ID: 9311477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial.
    Laffer U; Metzger U; Aeberhard P; Lorenz M; Harder F; Maibach R; Zuber M; Herrmann R
    Int J Colorectal Dis; 2008 Dec; 23(12):1233-41. PubMed ID: 18688620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparing the effect of adjuvant chemotherapy by portal vein infusion with intraluminal chemotherapy for colorectal cancer].
    Pan ZZ; Wan DS; Lu ZH; Li LR; Chen G; Zhou ZW; Wu XJ; Ding PR; Wang FL
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):918-21. PubMed ID: 15363253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of prophylactic intraportal chemotherapy on liver function, blood profile and survival in patients with colo-rectal cancer].
    Inoue Y; Sawada T; Shimizu T; Ishiguro M; Wakatsuki T; Hamazoe R; Shimizu N; Maeta M; Koga S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3024-7. PubMed ID: 2506834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.